Literature DB >> 8101115

Bronchodilator treatment in asthma. Increase in deaths during salmeterol treatment unexplained.

M R Sears, D R Taylor.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8101115      PMCID： PMC1677979          DOI： 10.1136/bmj.306.6892.1610-c

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  5 in total

1.  Patients at risk for dying of asthma: New Zealand experience.

Authors:  M R Sears; H H Rea
Journal:  J Allergy Clin Immunol       Date:  1987-09       Impact factor: 10.793

2.  Respiratory arrests in young asthmatics on salmeterol.

Authors:  C E Clark; A D Ferguson; J A Siddorn
Journal:  Respir Med       Date:  1993-04       Impact factor: 3.415

3.  A comparison of salmeterol with albuterol in the treatment of mild-to-moderate asthma.

Authors:  D S Pearlman; P Chervinsky; C LaForce; J M Seltzer; D L Southern; J P Kemp; R J Dockhorn; J Grossman; R F Liddle; S W Yancey
Journal:  N Engl J Med       Date:  1992-11-12       Impact factor: 91.245

4.  Serevent nationwide surveillance study: comparison of salmeterol with salbutamol in asthmatic patients who require regular bronchodilator treatment.

Authors:  W Castle; R Fuller; J Hall; J Palmer
Journal:  BMJ       Date:  1993-04-17

5.  Regular inhaled beta-agonist treatment in bronchial asthma.

Authors:  M R Sears; D R Taylor; C G Print; D C Lake; Q Q Li; E M Flannery; D M Yates; M K Lucas; G P Herbison
Journal:  Lancet       Date:  1990-12-08       Impact factor: 79.321
  5 in total
  3 in total

1.  The safety and effects of the beta-blocker, nadolol, in mild asthma: an open-label pilot study.

Authors:  Nicola A Hanania; Supria Singh; Rami El-Wali; Michael Flashner; Amie E Franklin; William J Garner; Burton F Dickey; Sergio Parra; Stephen Ruoss; Felix Shardonofsky; Brian J O'Connor; Clive Page; Richard A Bond
Journal:  Pulm Pharmacol Ther       Date:  2007-07-17       Impact factor: 3.410

2.  Drug use and pulmonary death rates in increasingly symptomatic asthma patients in the UK.

Authors:  C R Meier; H Jick
Journal:  Thorax       Date:  1997-07       Impact factor: 9.139

3.  Long-acting β-agonists in asthma management: what is the current status?

Authors:  Satya Mysore; Richard E Ruffin
Journal:  Drugs       Date:  2011-11-12       Impact factor: 9.546
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.